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Cadherins are cell-cell adhesion molecules. During
tumor progression, their expression and/or function are
frequently altered. E-cadherin down-regulation is often
associated with tumor initiation and progression in
breast cancer [1], whereas P-cadherin overexpression is
associated with a worse patient survival [2] and with
invasive breast cancer cells [3].
In this study, we aimed to understand if P-cadherin
overexpression could interfere with E-cadherin invasion
suppressor role in breast cancer.
Therefore, E- and P-cadherin expression was evaluated
in a series of invasive breast carcinomas. P-cadherin over-
expressing tumors often do not loose E-cadherin and
tumors co-expressing both cadherins showed a more
aggressive behavior and were related with the worst
patient survival. Further, we performed in vitro studies by
silencing both cadherins in BT-20 breast cancer cells. E-
and P-cadherin co-expressing breast cancer cells showed
increased cell invasion and migration capacities, when
compared with the ones expressing only one cadherin.
P-cadherin silencing led to increased levels of cell death,
demonstrating it as a cancer cell survival signal. Also,
microarrays of BT-20 cells, after E- and/or P-cadherin
silencing, showed that the role of each cadherin alone is
distinct from when these are co-expressed in the same
cell, conferring different transcriptional programs.
We can conclude that E- and P-cadherin co-expres-
sion has an invasion promoter role in breast cancer cells
and is a poor patient prognostic biomarker.
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